Paul E. Zarek

Array ( [id] => 6064475 [patent_doc_number] => 20110201665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Compositions, Methods, and Kits for Treating Influenza Viral Infections' [patent_app_type] => utility [patent_app_number] => 12/855046 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20055 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201665.pdf [firstpage_image] =>[orig_patent_app_number] => 12855046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6388305 [patent_doc_number] => 20100317650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'IMIDAZOPYRIDINE DERIVATIVES USEFUL AS INOS INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/849571 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18112 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317650.pdf [firstpage_image] =>[orig_patent_app_number] => 12849571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669060 [patent_doc_number] => 20110318329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'METHOD OF TREATMENT OR PROPHYLAXIS' [patent_app_type] => utility [patent_app_number] => 12/849727 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 36563 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12849727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993568 [patent_doc_number] => 20110015221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'PHARMACEUTICAL COMPOSITION OF VINFLUNINE WHICH IS INTENDED FOR PARENTERAL ADMINISTRATION PREPARATION METHOD THEREOF AND USE OF SAME' [patent_app_type] => utility [patent_app_number] => 12/846334 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3865 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015221.pdf [firstpage_image] =>[orig_patent_app_number] => 12846334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601159 [patent_doc_number] => 20100292344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Methods and Compositions for Treating Thalamocortical Dysrhythmia' [patent_app_type] => utility [patent_app_number] => 12/843108 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14544 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292344.pdf [firstpage_image] =>[orig_patent_app_number] => 12843108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033304 [patent_doc_number] => 20110082147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'SUBSTITUTED IMIDAZOTRIAZINES' [patent_app_type] => utility [patent_app_number] => 12/842589 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16903 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082147.pdf [firstpage_image] =>[orig_patent_app_number] => 12842589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8220763 [patent_doc_number] => 20120134963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING VIRUS EFFICACY' [patent_app_type] => utility [patent_app_number] => 13/382355 [patent_app_country] => US [patent_app_date] => 2010-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 17300 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9020539 [patent_doc_number] => 08530525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Methods and compositions for protecting and treating neuroinjury' [patent_app_type] => utility [patent_app_number] => 12/829056 [patent_app_country] => US [patent_app_date] => 2010-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 8459 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12829056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066009 [patent_doc_number] => 20110244018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'DECONTAMINANT EDIBLE PRODUCT, METHODS OF PRODUCTION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/827679 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13788 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20110244018.pdf [firstpage_image] =>[orig_patent_app_number] => 12827679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386235 [patent_doc_number] => 08263635 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Inhibitors of CYP 17' [patent_app_type] => utility [patent_app_number] => 12/824845 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72407 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12824845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10103744 [patent_doc_number] => 09139518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Amine derivative having NPY Y5 receptor antagonistic activity' [patent_app_type] => utility [patent_app_number] => 12/823568 [patent_app_country] => US [patent_app_date] => 2010-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39379 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12823568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670140 [patent_doc_number] => 20110319409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => '7-AZA-QUINAZOLINE PDE10 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/821311 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14855 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12821311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9957718 [patent_doc_number] => 09005920 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'Solution for cell-free protein synthesis, kit for cell-free protein synthesis, and method of protein synthesis' [patent_app_type] => utility [patent_app_number] => 13/378313 [patent_app_country] => US [patent_app_date] => 2010-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7455 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289330 [patent_doc_number] => 20120177656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'Compounds and Methods for the Modulation of Sulfilimine Bond Formation' [patent_app_type] => utility [patent_app_number] => 13/376687 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10009 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026430 [patent_doc_number] => 20110053999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => '4-METHYLPYRAZOLE FORMULATIONS FOR INHIBITING ETHANOL INTOLERANCE' [patent_app_type] => utility [patent_app_number] => 12/797594 [patent_app_country] => US [patent_app_date] => 2010-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16434 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053999.pdf [firstpage_image] =>[orig_patent_app_number] => 12797594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127854 [patent_doc_number] => 20110086847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'THIADIAZOLE MODULATORS OF BETA ADRENERGIC RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/797457 [patent_app_country] => US [patent_app_date] => 2010-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10536 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086847.pdf [firstpage_image] =>[orig_patent_app_number] => 12797457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095151 [patent_doc_number] => 20110002875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'METHOD FOR TREATING AMYLOIDOSIS' [patent_app_type] => utility [patent_app_number] => 12/795951 [patent_app_country] => US [patent_app_date] => 2010-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11924 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002875.pdf [firstpage_image] =>[orig_patent_app_number] => 12795951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6501068 [patent_doc_number] => 20100286278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Composition comprising an HDAC inhibitor in combination with a retinoid' [patent_app_type] => utility [patent_app_number] => 12/801347 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11772 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286278.pdf [firstpage_image] =>[orig_patent_app_number] => 12801347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783846 [patent_doc_number] => 20120045402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'DENTIFRICE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/266998 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6325 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045402.pdf [firstpage_image] =>[orig_patent_app_number] => 13266998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095235 [patent_doc_number] => 20110002896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT' [patent_app_type] => utility [patent_app_number] => 12/782324 [patent_app_country] => US [patent_app_date] => 2010-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17494 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002896.pdf [firstpage_image] =>[orig_patent_app_number] => 12782324 [rel_patent_id] =>[rel_patent_doc_number] =>)